TipRanks
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
Japanese Market
4552
JCR Pharmaceuticals Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4552 full AI Analyst Report?

JCR Pharmaceuticals Co., Ltd. (4552) Stock News & Sentiment

1 Followers
Italfarmaco Secures Exclusive Rights to JCR’s Hunter Syndrome Therapy JR-141 in Key Global Markets
Premium
Company Announcements
Italfarmaco Secures Exclusive Rights to JCR’s Hunter Syndrome Therapy JR-141 in Key Global Markets
8d ago
4552
JCR Pharmaceuticals Deepens Fucosidosis Research With New Long-Term Patient Study
Premium
Company Announcements
JCR Pharmaceuticals Deepens Fucosidosis Research With New Long-Term Patient Study
2M ago
4552
JCR Pharmaceuticals Posts Wider Quarterly Loss but Keeps Earnings and Dividend Outlook Intact
Premium
Company Announcements
JCR Pharmaceuticals Posts Wider Quarterly Loss but Keeps Earnings and Dividend Outlook Intact
2M ago
4552
JCR Pharmaceuticals Releases FY2026 Q1 Briefing Materials With Key Investor Disclaimers
Premium
Company Announcements
JCR Pharmaceuticals Releases FY2026 Q1 Briefing Materials With Key Investor Disclaimers
2M ago
4552
JCR Pharmaceuticals Completes Restricted Stock Compensation Transaction
Premium
Company Announcements
JCR Pharmaceuticals Completes Restricted Stock Compensation Transaction
3M ago
4552
JCR Pharmaceuticals Sets 2026–2027 Timeline to Launch Givinostat for Duchenne Muscular Dystrophy in Japan
Premium
Company Announcements
JCR Pharmaceuticals Sets 2026–2027 Timeline to Launch Givinostat for Duchenne Muscular Dystrophy in Japan
3M ago
4552
JCR Pharmaceuticals Corrects FY2025 Results as Profit Rebounds and Dividend Held Steady
Premium
Company Announcements
JCR Pharmaceuticals Corrects FY2025 Results as Profit Rebounds and Dividend Held Steady
4M ago
4552
More JP:4552 News >

4552 News on the Web

Italfarmaco Secures Exclusive Rights to JCR’s Hunter Syndrome Therapy JR-141 in Key Global Markets
TipRanks News
Bullish
JCR Pharmaceuticals Sets 2026–2027 Timeline to Launch Givinostat for Duchenne Muscular Dystrophy in Japan
TipRanks News
Bullish
JCR Deepens Strategic Alliance With Major Shareholder MEDIPAL While Maintaining Independence
TipRanks News
Bullish
JCR Pharmaceuticals to Grant Restricted Treasury Shares as Long-Term Incentive
TipRanks News
Bullish
JCR Pharmaceuticals Corrects FY2025 Results as Profit Rebounds and Dividend Held Steady
TipRanks News
Bullish
JR-446 Trial Signals Early Rare-Disease Catalyst for Medipal and JCR
TipRanks News
Bullish
JCR Pharmaceuticals Co., Ltd. (4552) Receives a Hold from Nomura
TipRanks News
Neutral
Citi Sticks to Its Hold Rating for JCR Pharmaceuticals Co., Ltd. (4552)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
JP:4552
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4552’s Media Buzz Sentiment?
1 articles about JP:4552 were published this week. In an average week, 0.25 articles are published.
    What is JP:4552’s weekly average amount of articles?
    In an average week, 0.25 articles about JP:4552 are published.
      What is JP:4552’s News Sentiment?
      100% of articles about JP:4552 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CMXHFCSL
        RZLTRezolute
        AMGNAmgen
        PMCUFPro Medicus Limited
        ABTAbbott Laboratories
        Showing the stocks with the most bullish news sentiment over the past week